NatureWise Biotech & Medicals Corporation

TPEX:4732 Stock Report

Market Cap: NT$1.2b

NatureWise Biotech & Medicals Balance Sheet Health

Financial Health criteria checks 6/6

NatureWise Biotech & Medicals has a total shareholder equity of NT$623.3M and total debt of NT$0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are NT$685.6M and NT$62.3M respectively. NatureWise Biotech & Medicals's EBIT is NT$11.4M making its interest coverage ratio -2.3. It has cash and short-term investments of NT$517.4M.

Key information

0%

Debt to equity ratio

NT$0

Debt

Interest coverage ratio-2.3x
CashNT$517.41m
EquityNT$623.28m
Total liabilitiesNT$62.34m
Total assetsNT$685.62m

Recent financial health updates

No updates

Recent updates

Lacklustre Performance Is Driving NatureWise Biotech & Medicals Corporation's (GTSM:4732) Low P/E

Apr 29
Lacklustre Performance Is Driving NatureWise Biotech & Medicals Corporation's (GTSM:4732) Low P/E

A Look At The Intrinsic Value Of NatureWise Biotech & Medicals Corporation (GTSM:4732)

Mar 25
A Look At The Intrinsic Value Of NatureWise Biotech & Medicals Corporation (GTSM:4732)

Here's Why We Don't Think NatureWise Biotech & Medicals's (GTSM:4732) Statutory Earnings Reflect Its Underlying Earnings Potential

Dec 20
Here's Why We Don't Think NatureWise Biotech & Medicals's (GTSM:4732) Statutory Earnings Reflect Its Underlying Earnings Potential

Financial Position Analysis

Short Term Liabilities: 4732's short term assets (NT$614.5M) exceed its short term liabilities (NT$53.4M).

Long Term Liabilities: 4732's short term assets (NT$614.5M) exceed its long term liabilities (NT$8.9M).


Debt to Equity History and Analysis

Debt Level: 4732 is debt free.

Reducing Debt: 4732 has not had any debt for past 5 years.

Debt Coverage: 4732 has no debt, therefore it does not need to be covered by operating cash flow.

Interest Coverage: 4732 has no debt, therefore coverage of interest payments is not a concern.


Balance Sheet


Discover healthy companies

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.